Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.38 | 0.1 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.09 | 0.1 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |